The end of bursectomy for gastric cancer?

Affiliations

¹ Centre for Surgical Research, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK; Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. Electronic address: benbyrne@doctors.org.uk.
² Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol, UK.
³ Centre for Surgical Research, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK; Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Comment

Ben E Byrne et al. Lancet Gastroenterol Hepatol. 2018 Jul.

. 2018 Jul;3(7):446-447.

doi: 10.1016/S2468-1253(18)30135-3. Epub 2018 Apr 28.

¹ Centre for Surgical Research, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK; Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. Electronic address: benbyrne@doctors.org.uk.
² Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol, UK.
³ Centre for Surgical Research, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK; Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

No abstract available

Comment on

Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
Kurokawa Y, Doki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, Kimura Y, Takiguchi S, Nishida Y, Fukushima N, Iwasaki Y, Kaji M, Hirao M, Katayama H, Sasako M. Kurokawa Y, et al. Lancet Gastroenterol Hepatol. 2018 Jul;3(7):460-468. doi: 10.1016/S2468-1253(18)30090-6. Epub 2018 Apr 28. Lancet Gastroenterol Hepatol. 2018. PMID: 29709558 Clinical Trial.